- Home
- OSUR vs OCGN Comparison
OSUR vs OCGN Comparison
Compare OSUR & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- OCGN
- Stock Information
- Founded
- OSUR 2000
- OCGN 2013
- Country
- OSUR United States
- OCGN United States
- Employees
- OSUR N/A
- OCGN N/A
- Industry
- OSUR Medical/Dental Instruments
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OSUR Health Care
- OCGN Health Care
- Exchange
- OSUR Nasdaq
- OCGN Nasdaq
- Market Cap
- OSUR 284.9M
- OCGN 229.2M
- IPO Year
- OSUR 1986
- OCGN N/A
- Fundamental
- Price
- OSUR $3.80
- OCGN $0.68
- Analyst Decision
- OSUR Hold
- OCGN Strong Buy
- Analyst Count
- OSUR 2
- OCGN 3
- Target Price
- OSUR $5.50
- OCGN $6.00
- AVG Volume (30 Days)
- OSUR 821.4K
- OCGN 3.5M
- Earning Date
- OSUR 02-25-2025
- OCGN 03-05-2025
- Dividend Yield
- OSUR N/A
- OCGN N/A
- EPS Growth
- OSUR N/A
- OCGN N/A
- EPS
- OSUR 0.15
- OCGN N/A
- Revenue
- OSUR $224,263,000.00
- OCGN $4,700,000.00
- Revenue This Year
- OSUR N/A
- OCGN N/A
- Revenue Next Year
- OSUR N/A
- OCGN N/A
- P/E Ratio
- OSUR $25.16
- OCGN N/A
- Revenue Growth
- OSUR N/A
- OCGN N/A
- 52 Week Low
- OSUR $3.52
- OCGN $0.64
- 52 Week High
- OSUR $8.04
- OCGN $2.11
- Technical
- Relative Strength Index (RSI)
- OSUR 45.88
- OCGN 40.75
- Support Level
- OSUR $3.73
- OCGN $0.67
- Resistance Level
- OSUR $4.01
- OCGN $0.76
- Average True Range (ATR)
- OSUR 0.11
- OCGN 0.04
- MACD
- OSUR -0.01
- OCGN 0.00
- Stochastic Oscillator
- OSUR 21.21
- OCGN 28.57
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").